ArticleCancer treatment communications2014
Patient, Physician and Contextual Factors Are Influential in the Treatment Decision Making of Older Adults Newly Diagnosed with Symptomatic Myeloma.
Article in Cancer treatment communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Symptom experiences and self-management strategies of patients with haematological malignancy undergoing chemotherapy: A qualitative study.Asia-Pacific journal of oncology nursing · 2024Article
- Patient, Care Partner, and Physician Voices in Treatment Decision-Making for Multiple Myeloma.Patient preference and adherence · 2024Article
- Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis.Future oncology (London, England) · 2024Article
- What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study.Cancers · 2023Article
- The Role of Nurse on the Treatment Decision Support for Older People with Cancer: A Systematic Review.Healthcare (Basel, Switzerland) · 2023Review
- Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers.BMJ open · 2022Article
- Article
- Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists.Leukemia & lymphoma · 2021Article
- Management of Acute Myeloid Leukemia (AML) in Older Patients.Current oncology reports · 2020Review
- Relatives of deceased patients with metastatic lung cancer's views on the achievement of treatment goals and the choice to start treatment: a structured telephone interview study.BMC palliative care · 2020Article
- Electronic Health Record Documentation Patterns of Recorded Primary Care Visits Focused on Complex Communication: A Qualitative Study.Applied clinical informatics · 2019Article
- Development of the "Treatment beliefs in knee and hip OsteoArthritis (TOA)" questionnaire.BMC musculoskeletal disorders · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
aimsTo examine patient perspectives on their personal and contextual factors relevant to TDM. The second aim was to describe physician perspectives on the TDM in older adults (≥60 y.o.) diagnosed with symptomatic MM. STUDY
designDescriptive, cross-sectional. METHODOLOGY: A semi-structured interview schedule was administered. Directed content analysis procedures were used to develop major themes from the patient and physician participant interviews.
resultsThemes related to treatment decision making among patient participants include various decisional role preferences; several sources of information related to myeloma; contextual and patient-specific factors influence treatment decisions; negative perceptions related to the treatment decision-making process exist; strong desire to be in remission and to live a longer life; For physician participants, top themes related to decision making were: QOL or survival considerations or simultaneously considerations of treatment effectiveness, QOL and survival; screening patients for eligibility for autologous HSCT; time is a barrier to effective TDM; Various methods were used to assess patient decisional role preferences.
conclusionsTreatment decision making in older adults newly diagnosed with symptomatic myeloma is influenced by personal, social and contextual factors. Patients must be given the opportunity to choose the best possible treatment within the limits of the patient's personal, social and medical contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.